Form 4 for CI Cigna
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001225208-24-003706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-01 | CI | BRAILER DAVID J | EVP, Chief Health Off | F - Tax | $333.36 | -1,511 | 9,332 | -14% | -$503.7K |
| 2024-03-05 | 2024-03-01 | CI | BRAILER DAVID J | EVP, Chief Health Off | A - Grant | $0.00 | +2,780 | 10.8K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2024-03-01 | F | D | 412 | $333.36 | 10,431 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| 2 | Common | Common Stock, $.01 Par Value | 2024-03-01 | A | A | 2,780 | $0.00 | 10,843 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| 3 | Common | Common Stock, $.01 Par Value | 2024-03-01 | F | D | 1,099 | $333.36 | 9,332 | D | — | — | (F3) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |